Journal of Stem Cell Research & Therapy

Miller MA, Fingert JH, Bettis DI (2016) CURRENT OPINION Genetics and genetic testing for glaucoma. Curr Opin Ophthalmol.  

Alonso-Alonso ML, Srivastava GK (2015) Name of journal: World Journal of Stem Cells ESPS Manuscript NO: 14409 Columns: Minireviews Current focus of stem cell application in retinal repair.

Gill KP, Hung SS, Sharov A, Lo CY, Needham K, et al. (2016) Enriched retinal ganglion cells derived from human embryonic stem cells. Scientific Reports.

Scheetz TE, Roos BR, Solivan-Timpe F, Miller K, DeLuca AP, et al. (2016) SQSTM1 mutations and glaucoma. PloS one11: e0156001.

Cooke JA, Meyer JS (2015) Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies. Current ophthalmology reports 3: 200-206.

Wiggs JL (2015) Mitochondrial genetics and optic neuropathy. Annual Review of Vision Science1: 97-124.  

Khan S, Hung SS, Wong RC (2016) The use of induced pluripotent stem cells for studying and treating optic neuropathies. Current opinion in organ transplantation 21: 484-489.

Tucker BA, Cranston CM, Anfinson KA, Shrestha S, Streb LM, et al. (2015) Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial. Translational Research 166: 740-749.

Giacalone JC, Wiley LA, Burnight ER, Songstad AE, Mullins RF, et al. (2016) Concise Review: Patient‐Specific Stem Cells to Interrogate Inherited Eye Disease. Stem cells translational medicine 5: 132-140.

Tucker BA, Cranston C, Anfinson KA, Shrestha S, Streb LM, et al. (2015) Using patient specific iPSCs to interrogate the pathogenicity of a novel RPE65 cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial. Translational research: the journal of laboratory and clinical medicine 66: 740.

Wiggs JL (2015) Chapter Nineteen-Glaucoma Genes and Mechanisms. Progress in molecular biology and translational science 134: 315-342.

Kumar S, Malik MA, Goswami S, Sihota R, Kaur J (2016) Candidate genes involved in the susceptibility of primary open angle glaucoma. Gene 577: 119-131.

Sirohi K, Kumari A, Radha V, Swarup G (2015) A glaucoma-associated variant of optineurin, M98K, activates Tbk1 to enhance autophagosome formation and retinal cell death dependent on Ser177 phosphorylation of optineurin. PloS one 10: e0138289.

Ohlemacher SK, Sridhar A, Xiao Y, Hochstetler AE, Sarfarazi M, et al. (2016) Stepwise differentiation of retinal ganglion cells from human pluripotent stem cells enables analysis of glaucomatous neurodegeneration. Stem Cells 34: 1553-1562.

Koch JC, Lingor P (2016) The role of autophagy in axonal degeneration of the optic nerve. Experimental eye research 144: 81-89.

Alonso-Alonso ML, Srivastava GK (2015) Current focus of stem cell application in retinal repair. World journal of stem cells.7: 641.

Nguyen HV, Li Y, Tsang SH (2015) Patient-specific iPSC-derived RPE for modeling of retinal diseases. Journal of clinical medicine. 4: 567-578.

Onos KD, Rizzo SJ, Howell GR, Sasner M (2016) Toward more predictive genetic mouse models of Alzheimer's disease. Brain research bulletin 122: 1-1.

Fernandes KA, Harder JM, Williams PA, Rausch RL, Kiernan AE, et al. (2015) Using genetic mouse models to gain insight into glaucoma: past results and future possibilities. Experimental eye research 141: 42-56.

Wiley LA, Burnight ER, Songstad AE, Drack AV, Mullins RF, et al. (2015) Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases. Progress in retinal and eye research 44: 15-35.